Israeli researchers pioneer paradigm shift in cancer treatment

An entirely new way to fight cancer is almost ready to go public.

The American Food and Drug Administration unanimously recommended a revolutionary new cancer treatment for its final approval. and it’s a paradigm shift in how doctors and researchers treat certain cancers.

Cancer is difficult for a person’s immune system to fight on its own – the disease occurs when the body’s own cells turn against it, so the immune system does not always recognize it in the same way would a foreign threat. Even when it does, it is not always enough to stop the spread.

A group of Israeli scientists has discovered that the trick is to modify the immune system. By using the Chimeric Antigen Receptor T-Cell Therapy (CAR-T) to genetically modify T-cells, the cells that fight the virus-infected cells, a stronger version of the original system can be created, with the added ability of detecting and hunting specific cancers.

“We take blood from the patient, and we isolate the blood immune cells before inserting a new gene into the cells. This new gene actually educates the T-Cells, makes them able to recognize the tumor cells,’ explains Dr. Michal Besser, Head of Laboratory at Israel’s Sheba Medical Center’s Ella Lemelbaum Institute for Immuno-Oncology.

The modified cells are then replicated in a lab and reintroduced into the patient’s body where they multiply even more– fortifying the immune system with the new stronger and more aggressive T-cells.

Read More: I-24 News